|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT01068002 |
|
Date of registration:
|
11/02/2010 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
CREATION-P |
|
Scientific title:
|
Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01) |
|
Date of first enrolment:
|
June 2009 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01068002 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Limor I Bushari |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Heart Institute, Ha'Emek Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- hypertension during pregnancy: Chronic or pregnancy induced
Exclusion Criteria:
- Inability to sign informed consent
Age minimum:
18 Years
Age maximum:
60 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Pregnancy
|
|
Primary Outcome(s)
|
|
Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment
[Time Frame: 1 year]
|
|
Secondary Outcome(s)
|
|
Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women
[Time Frame: 1 Year]
|
|
Secondary ID(s)
|
|
071-09-EMC
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|